Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin for inflammatory factors in women with unexplained infertility undergoing artificial insemination
IRCT20200421047152N3Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in female infertility comparing Simvastatin receiving group with Placebo receiving group (2 arms). Primary endpoints: Serum tumor necrosis factor-alpha, Serum interleukin-1 and 2 more. Started Sep 2023; status: completed.
02
Drugs
simvastatin
03
Conditions
female infertility
Beyond the preview
Go deeper on IRCT20200421047152N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200421047152N3.